Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients

Prostate

Volumn 29, Issue SUPPL. 7, 1996, Pages 25-29

  Holmes, Eric H ^a   Greene, Thomas G ^a   Tino, William T ^a   Boynton, Alton L ^a   Aldape, Hector C ^a   Misrock, S Leslie ^b   Murphy, Gerald P ^a,c  

^a NORTHWEST HOSPITAL   (United States)

^b Pennie and Edmonds   (United States)

^c NONE   (United States)

Author keywords

glycoprotein, glycosylation; prostate cancer; prostate specific membrane antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; GLYCOSIDASE;

ANTIGEN DETECTION; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; AMINO ACID SEQUENCE; ARTICLE; BLOOD; CARCINOMA; CELL CULTURE; DRUG EFFECT; GENETICS; GLYCOSYLATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROSTATE TUMOR;

AMINO ACID SEQUENCE; CARCINOMA; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030341967     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(1996)7+<25::AID-PROS3>3.0.CO;2-I     Document Type: Conference Paper

References (11)

1. Horoszewicz JS, Kawinski E, Murphy GP: Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostate cancer patients. Anticancer Res 7:927-936, 1987.
2. Abdel-Nabi H, Wright GL, Gulfo JV, Petrylak DP, Neal CE, Texter JE, Begun FP, Tyson I, Heal A, Mitchell E, Purnell G, Harwood SJ: Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Semin Urol 10:45-54, 199.
3. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WDW: Expression of the prostate-specific membrane antigen. Cancer Res 54:1807-1811, 1994.
4. Israeli RS, Miller WH, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WDW: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostate tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54:6306-6310, 1994.
5. Rochon YP, Horoszewicz JS, Boynton AL, Holmes EH, Barren RJ, Erickson SJ, Kenny GM, Murphy GP: Western blot assay for prostate specific membrane antigen in serum of prostate cancer patients. Prostate 25:219-223, 1994.
6. Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, Barren RJ: A comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP based ELISA assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate 26:164-168, 1995.
7. Murphy G, Ragde H, Kenny G, Barren R, Erickson S, Tjoa B, Boynton A, Holmes E, Gilbaugh J, Douglas T: Comparison of prostate specific membrane antigen and prostate specific antigen levels in prostatic cancer patients. Anticancer Res 15:1473-1479, 1995.
8. Israeli RS, Powell CT, Fair WR, Heston WDW: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53:227-230, 1993.
9. Carter RE, Feldman AR, Coyle JT: Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologie characteristics of a neuropeptidase. Proc Natl Acad Sci USA 93:749-753, 1996.
10. Pelletier DB, Boynton A: Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication. J Cell Physiol 158: 427-434, 1994.
11. Troyer JK, Feng Q, Beckett ML, Wright Jr GL: Biochemical characterization and mapping of the 7E11.C5 epitope of the prostate-specific membrane antigen. Urol Oncol 1:29-37, 1995.